F.M. Ribeiro Laia et al. / Tetrahedron 66 (2010) 8815e8822
8821
3-carboxylate (15). Mp 117.0e118.0 ꢀC (from methanol). IR (film)
3063, 1740, 1675, 1228 and 1151 cmꢁ1 1H NMR (CDCl3, 400 MHz)
171.6, 172.6; MS (ESI) m/z 512 (MHþ, 100%), 201 (76) and 195 (25).
HRMS (ESI) m/z 512.27993 (C33H38NO4 [MHþ], 512.27954).
;
3.63 (1H, d, J¼12.8 Hz), 3.86 (1H, d, J¼12.8 Hz), 4.28e4.30 (1H, m),
4.61 (1H, d, J¼12.4 Hz), 4.85 (1H, d, J¼12.4 Hz), 5.06 (1H, br s), 5.27
(1H, d, J¼8.0 Hz), 5.30 (1H, br s), 5.48 (1H, s), 7.02e7.15 (7H, m,
AreH), 7.22e7.24 (3H, m, AreH), 7.31e7.34 (2H, m, AreH),
7.42e7.46 (2H, m, AreH), 7.49e7.58 (2H, m, AreH), 7.65e7.67 (2H,
m, AreH), 7.92e7.94 (2H, m, AreH); 13C NMR (CDCl3,100 MHz) 51.9,
53.4, 63.4, 66.9, 71.0, 111.6, 127.4, 128.1, 128.2, 128.3, 128.4, 128.5,
129.0, 129.3, 133.0, 133.1, 134.8, 136.4, 137.5, 142.8, 169.0, 199.5,
200.3; MS (ESI) m/z 516 (MHþ, 100%), 517 (35) and 518 (5). HRMS
(ESI) m/z 516.21632 (C34H30NO4 [MHþ], 516.21693); Benzyl 2,5-
dibenzoyl-1-benzyl-4-methylenepyrrolidine-3-carboxylate (16). IR
4.3.16. 4-Benzyl 2-ethyl 1-benzyl-3-benzylidene-5-phenylpyrrolidine-
2,4-dicarboxylate (18d). Prepared by method A from aziridine 17
(100 mg, 0.36 mmol) and allene 3d (0.43 mmol). Crystallization from
methanol afforded 18d as
a white solid in 48% yield. Mp
118.6e119.9 ꢀC (from methanol). IR (KBr) 3031, 1730, 1257 and
1154 cmꢁ1
;
1H NMR (CDCl3, 400 MHz) 1.26 (3H, t, J¼7.2 Hz), 3.59
(1H, d, J¼13.6 Hz), 3.92 (1H, d, J¼13.6 Hz), 4.14e4.21 (3H, m), 4.35
(1H, d, J¼8.0 Hz), 4.54 (1H, s), 4.65 (1H, d, J¼12.4 Hz), 5.13 (1H, d,
J¼8.0 Hz), 6.68 (1H, s), 6.93e6.95 (2H, m, AreH), 7.18e7.35 (16H, m,
AreH), 7.49e7.51 (2H, m, AreH); 13C NMR (CDCl3, 100 MHz) 14.4,
51.1, 54.1, 60.5, 66.5, 67.7, 69.8, 126.7, 127.1, 127.4, 128.0, 128.1, 128.2,
128.3, 128.4, 128.5, 135.4, 136.1, 136.3, 138.0, 138.3, 170.1, 171.9; MS
(ESI) m/z 532 (MHþ, 100%) and 201 (28). HRMS (ESI) m/z 532.24948
(C35H34NO4 [MHþ], 532.24824).
(film) 3063, 1737, 1686, 1228 and 1159 cmꢁ1 1H NMR (CDCl3,
;
400 MHz) 3.78e3.79 (1H, m), 3.85 (1H, d, J¼12.4 Hz), 3.94 (1H, d,
J¼12.4 Hz), 5.04 (1H, br s), 5.15 (2H, s), 5.30 (1H, br s), 5.34 (1H, br
s), 5.53 (1H, d, J¼4.4 Hz), 7.15e7.39 (14H, m, AreH), 7.50e7.56 (2H,
m, AreH), 7.84e7.90 (4H, m, AreH); MS (ESI) m/z 516 (MHþ, 100%),
201 (44), 233 (14) and 207 (15). HRMS (ESI) m/z 516.21749
(C34H30NO4 [MHþ], 516.21693).
4.3.17. 4-Benzyl 2-ethyl 1-benzyl-3-phenethylidene-5-phenylpyrroli-
dine-2,4-dicarboxylate (18e). Prepared by method A from aziridine
17 (100 mg, 0.36 mmol) and allene 3e (0.43 mmol). Crystallization
from methanol afforded 18e as a white solid in 56% yield. Mp
94.3e95.2 ꢀC (from methanol). IR (KBr) 2931, 1722, 1603, 1277 and
4.3.13. 4-Benzyl 2-ethyl 1-benzyl-3-methylene-5-phenylpyrrolidine-
2,4-dicarboxylate (18a). Prepared by method A from aziridine 17
(100 mg, 0.36 mmol) and allene 3a (0.43 mmol). Crystallization
from methanol afforded 18a as a yellow solid in 73% yield. Mp
84.0e86.0 ꢀC (from methanol). IR (KBr) 3026, 1738, 1247 and
1159 cmꢁ1
;
1H NMR (CDCl3, 400 MHz) 1.17 (3H, t, J¼7.2 Hz), 3.23
(2H, d, J¼7.6 Hz), 3.59 (1H, d, J¼14.0 Hz), 3.89 (1H, d, J¼14.0 Hz),
4.08e4.14 (3H, m), 4.38 (1H, d, J¼12.4 Hz), 4.41 (1H, s), 4.75 (1H,
d, J¼12.4 Hz), 5.09 (1H, d, J¼8.0 Hz), 5.84 (1H, t, J¼7.6 Hz)),
7.03e7.05 (4H, m, AreH), 7.20e7.33 (14H, m, AreH), 7.49e7.51
(2H, m, AreH); 13C NMR (CDCl3, 100 MHz) 14.3, 35.6, 51.0, 53.3,
60.4, 65.9, 66.6, 69.1, 125.9, 126.2, 127.1, 127.7, 127.9, 128.1, 128.3,
128.4, 128.7, 135.4, 136.4, 138.0, 138.4, 139.4, 170.8, 172.1; MS (ESI)
m/z 546 (MHþ, 100%), 287 (3) and 201 (6). HRMS (ESI) m/z
546.26447 (C36H36NO4 [MHþ], 546.26389.
1152 cmꢁ1
;
1H NMR (CDCl3, 400 MHz) 1.24 (3H, t, J¼7.2 Hz), 3.55
(1H, d, J¼13.6 Hz), 3.81 (1H, d, J¼13.6 Hz), 4.09 (1H, d, J¼8.4 Hz),
4.13e4.18 (2H, m), 4.38 (1H, s), 4.43 (1H, d, J¼12.4 Hz), 4.77 (1H, d,
J¼12.4 Hz), 4.94 (1H, d, J¼8.4 Hz), 5.23 (1H, br s), 5.39 (1H, br s),
7.01e7.02 (2H, m, AreH), 7.29e7.32 (11H, m, AreH), 7.39e7.41 (2H,
m, AreH); 13C NMR (CDCl3, 100 MHz) 14.3, 51.6, 54.6, 60.6, 66.5,
66.7, 68.6, 112.1, 127.1, 128.0, 128.1, 128.2, 128.3, 128.4, 128.6, 135.4,
138.2, 138.3, 143.7, 170.7, 171.8; MS (ESI) m/z 456 (MHþ, 100%), 201
(17) and 195 (15). HRMS (ESI) m/z 456.21580 (C29H30NO4 [MHþ],
456.21693).
4.3.18. 4-Benzyl 2-ethyl1-cyclohexyl-3-methylene-5-phenylpyrrolidine-
2,4-dicarboxylate (20). Prepared by method A from aziridine 19
(100 mg, 0.37 mmol) and allene 3a (0.44 mmol). Crystallization
from methanol afforded 20 as a white solid in 62% yield. Prepared
by method B hating the toluene solution of aziridine 19 (100 mg,
0.37 mmol) and allene 3a (0.44 mmol) for 3 h. Purification by
flash column chromatography [ethyl acetateehexane (1:8)]
afforded 20 as a yellow oil in 40% yield. Mp 96.5e98.0 ꢀC (from
4.3.14. 4-Benzyl 2-ethyl 1-benzyl-3-ethylidene-5-phenylpyrrolidine-
2,4-dicarboxylate (18b). Prepared by method A from aziridine 17
(100 mg, 0.36 mmol) and allene 3b (0.43 mmol). Purification by
flash column chromatography [ethyl acetateehexane (1:9)] affor-
ded 18b as a white solid in 50% yield. Mp 72.0e74.0 ꢀC (from
methanol). IR (film) 3031, 1733, 1256 and 1151 cmꢁ1
;
1H NMR
methanol). IR (KBr) 2930, 1745, 1237 and 1187 cmꢁ1 1H NMR
;
(CDCl3, 400 MHz) 1.22 (3H, t, J¼7.2 Hz), 1.52 (3H, d, J¼6.8 Hz), 3.55
(1H, d, J¼14.0 Hz), 3.86 (1H, d, J¼14.0 Hz), 3.99 (1H, d, J¼8.0 Hz),
4.14 (2H, q, J¼7.2 Hz), 4.35 (1H, s), 4.40 (1H, d, J¼12.0 Hz), 4.78 (1H,
d, J¼12.0 Hz), 5.04 (1H, d, J¼8.0 Hz), 5.72 (1H, q, J¼6.8 Hz),
7.02e7.03 (2H, m, AreH), 7.23e7.34 (11H, m, AreH), 7.48e7.50 (2H,
m, AreH); 13C NMR (CDCl3, 100 MHz) 14.3, 15.0, 51.1, 53.0, 60.3,
65.9, 66.5, 69.0, 122.0, 127.0, 128.0, 128.2, 128.3, 128.3, 128.4, 128.4,
135.6, 136.1, 138.2, 138.5, 170.8, 172.3; MS (ESI) m/z 470 (MHþ,
100%), 211 (12) and 201 (28). HRMS (ESI) m/z 470.23076
(C30H32NO4 [MHþ], 470.23258).
(CDCl3, 400 MHz) 1.25 (3H, br s), 1.29 (3H, t, J¼7.2 Hz), 1.45e1.48
(1H, m), 1.55e1.62 (3H, m), 1.78e1.86 (3H, m), 2.41e2.46 (1H, m),
4.21 (2H, q, J¼7.2 Hz), 4.25e4.28 (1H, m), 4.54 (1H, d, J¼12.0 Hz),
4.54 (1H, s), 4.76 (1H, d, J¼12.0 Hz), 4.92 (1H, d, J¼8.4 Hz), 5.42
(1H, br s), 5.50 (1H, br s), 7.12e7.13 (4H, m, AreH), 7.20e7.22 (3H,
m, AreH), 7.29e7.31 (3H, m, AreH); 13C NMR (CDCl3, 100 MHz)
14.2, 25.0, 25.4, 25.8, 31.0, 32.5, 52.2, 57.5, 60.9, 66.2, 66.5, 68.1,
112.0, 127.5, 127.9, 128.1, 128.3, 128.4, 135.5, 139.7, 142.5, 169.3,
174.3; MS (ESI) m/z 448 (MHþ, 100%) and 274 (8). HRMS (ESI) m/z
448.24723 (C28H34NO4 [MHþ], 448.24824).
4.3.15. 4-Benzyl 2-ethyl 1-benzyl-3-(2,2-dimethylpropylidene)-5-
phenylpyrrolidine-2,4-dicarboxylate (18c). Prepared by method A
from aziridine 17 (100 mg, 0.36 mmol) and allene 3c (0.43 mmol).
Crystallization from methanol afforded 18c as a white solid in 71%
yield. Mp 138.0e140.0 ꢀC (from methanol). IR (KBr) 2952, 1724,
4.4. General procedure for formal [3D2] cycloaddition of
2-benzoyl-1-tert-butyl-3-phenylaziridine (9) with allenes
A solution of aziridine 9 (100 mg, 0.36 mmol) and the appro-
priated buta-2,3-dienoate (0.54 mmol) in toluene (6 mL) was
heated at 80 ꢀC for 4 h. The solvent was removed under reduced
pressure and the crude product was purified by flash chromatog-
raphy [ethyl acetateehexane (1:9)].
1257 and 1146 cmꢁ1 1H NMR (CDCl3, 400 MHz) 0.96 (9H, s), 1.21
;
(3H, t, J¼7.2 Hz), 3.53 (1H, d, J¼13.6 Hz), 3.88 (1H, d, J¼13.6 Hz),
4.05e4.22 (3H, m), 4.34 (1H, d, J¼12.0 Hz), 4.35 (1H, s), 4.81 (1H, d,
J¼12.0 Hz), 5.03 (1H, d, J¼7.6 Hz), 5.62 (1H, s), 7.02e7.03 (2H, m,
AreH), 7.22e7.34 (11H, m, AreH), 7.46e7.48 (2H, m, AreH); 13C
NMR (CDCl3, 100 MHz) 14.3, 29.8, 33.6, 50.8, 53.1, 60.1, 66.6, 67.1,
69.9, 127.0, 128.1, 128.3, 128.4, 128.5, 131.5, 135.4, 137.1, 138.3, 138.6,
4.4.1. Benzyl 1-tert-butyl-2-methyl-4-phenyl-1H-pyrrole-3-carbox-
ylate (10a). Cycloadduct 10a was obtained as a yellow oil in 65%
yield. IR (film) 2980, 1696, 1209 and 1143 cmꢁ1 1H NMR (CDCl3,
;